Article thumbnail

Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients

By Erling Tronvik, Lars J Stovner, Gunnar Bovim, Linda R White, Amanda J Gladwin, Kathryn Owen and Harald Schrader
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2311324
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A: Mast cells activate the renin angiotensin system and contribute to migraine: A hypothesis. Headache: The Journal of Head and Face Pain .
  2. (1995). ACE inhibitors for prophylaxis of migraine headaches. Headache
  3. (2000). Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol
  4. (2004). Assessing the impact of population stratification on genetic association studies. Nat Genet
  5. (2005). Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett
  6. (2006). Bovim G: Involvement of the renin-angiotensin system in migraine. J Hypertens Suppl
  7. (2003). Bovim G: Prophylactic treatment of migraine with an angiotensin II receptor blocker (Candesartan cilexetil): a randomized, placebo controlled, crossover study. JAMA
  8. (2001). Bovim G: Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ
  9. (2006). Case-control studies in the genomic era: a clinician's guide. Lancet Neurol
  10. (2002). Efficacy of angiotensin II receptor antagonists in preventing headache: a systematic overview and meta-analysis.
  11. (1981). Enkephalinase inhibition relieves pain syndromes of central dysnociception (migraine and related headache). Cephalalgia
  12. (2004). Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders, 2nd edn. Cephalalgia
  13. (2005). HJ: Homozygous deletion genotype og angiotensin converting enzyme confers protection against migraine in man. Acta Neurol Taiwan
  14. (2005). LR: Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res Mol Brain Res
  15. (1997). Practical statistics for medical research London:
  16. (1998). RH: ACE polymorphisms in women and risk of myocardial infarction.
  17. (1992). Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.
  18. (1992). Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res